Strategic Fund Medicine List / Lista de Medicamentos del Fondo Estratégico 1 Updated September

Size: px
Start display at page:

Download "Strategic Fund Medicine List / Lista de Medicamentos del Fondo Estratégico 1 Updated September"

Transcription

1 1 Updated September International Nonproprietary Name (INN) / Denominación Común Internacional (DCI) ANALGESICS Opioid analgesics Strength / Concentracion Presentation / Forma Farmacéutica Codeine 15mg; 30mg (phosphate) Morphine Morphine Morphine 10mg/ml (sulfate or hydrochloride) in 1ml ampoule 10mg/5ml (sulfate or hydrochloride) 10mg; 30mg; 60mg (sulfate) Oral Solution (prolonged release) Indication(s)/ Indicacion(es) Analgesic Analgesic; Anaesthetic; Preoperative and short procedures Analgesic; Palliative care Analgesic; Palliative care ANTI-INFECTIVE MEDICINES Antibacterial Amoxicillin + Clavulanic acid 500mg + 125mg Antibacterial Azithromycin 200mg/5ml Oral Solution Azithromycin (for Trachoma treatment) 250mg; 500mg (anhydrous) Antibacterial Benzathine benzylpenicillin Benzylpenicillin Procaine benzylpenicillin 900 mg benzylpenicillin (=1.2 million IU) in 5mL vial; 1.44 g benzylpenicillin (=2.4 million IU) in 5mL vial 600 mg (=1 million IU) (sodium or potassium salt) in vial; 3 g (=5 million IU) (sodium or potassium salt) in vial 1 g (=1 million IU); 3 g (= 3 million IU) in vial Doxycycline 100mg ; Capsule Sulfadiazine 500mg Antibacterial; Syphilis Antibacterial; Syphilis Antibacterial; Syphilis Antibacterial; Malaria prophylaxis and treatment Anti-pneumocystosis; Anti-toxoplasmosis Ref 2 1 The therapeutic indications presented in this list of medicines appear as published in the 20th World Health Organization Model List of Essential Medicines published March The Strategic Fund Medicine List does not seek to replace or complement the WHO the Essential Medicine List or Member States national essential medicine lists. As a result, this list should not be utilized as reference for the development of other essential medicine lists or treatment guidelines. - Las indicaciones terapéuticas se presentan con base en la decimonovena Lista de Medicamentos Esenciales de la Organización Mundial de la Salud publicada en Marzo La Lista de Medicamentos del Fondo Estratégico no supone ninguna complementación o ampliación de la Lista de Medicamentos Esenciales de la OMS o de las listas de medicamentos esenciales nacionales de los Estados Miembros. Consecuenteme nte, esta lista no debería ser utilizada como referencia para la elaboración de listas de medicamentos esenciales o guías de tratamiento. 2 Only used as single dose treatment of genital Chlamydia Trachomatis and of trachoma. - Solamente utilizado en dosis única para el tratamiento de chlamydia trachomatis genital y tracoma.

2 Antileprosy med. Clofazimine 50mg; 100mg Capsule Dapsone 25mg; 50mg; 100mg Leprosy 3 Ofloxacin 400mg Leprosy (second-line) 4 Antituberculosis med. Ethambutol 100mg; 400mg Ethambutol 25mg/ml Oral Solution Isoniazid 50mg/5ml Oral Solution Isoniazid 100mg (dispersable) Isoniazid 300mg Tuberculosis Pyrazinamide 400mg Pyrazinamide 150mg (scored); (dispersible) Pyrazinamide 30mg/ml Oral Solution Rifabutin 150mg Capsule 5 Rifampicin 20mg/ml Oral Solution Rifampicin 150mg; 300 mg ; Capsule Tuberculosis; Leprosy 3 Rifampicin + Isoniazid 75mg + 50mg (dispersable) Rifampicin + Isoniazid 60mg + 30mg (dispersable) Rifampicin + Isoniazid 150mg + 75mg ; 300mg + 150mg; 60mg + 60mg; 150mg + 150mg Rifampicin + Isoniazid + Ethambutol 150mg + 75mg + 275mg Tuberculosis Rifampicin + Isoniazid + Pyrazinamide 75mg + 50mg + 150mg (dispersable) Rifampicin + Isoniazid + Pyrazinamide 60mg + 30mg + 150mg (dispersable) Rifampicin + Isoniazid + Pyrazinamide 150mg + 75mg + 400mg; 150mg + 150mg + 500mg Rifampicin + Isoniazid + Pyrazinamide + 150mg + 75mg + 400mg + Ethambutol 275mg Rifapentine 150mg 6 Antiberculosis med. 2 nd line Amikacin 1g (sulfate) in vial Multidrug-resistant tuberculosis Bedaquiline 100mg (MDR/TB) 7 3 Medicines used in the treatment of leprosy should never be used except in combination. - Los medicamentos para el tratamiento de lepra siempre deben ser utilizados en combinación. 4 To be used in combination with rifampicin as a second-line therapy for leprosy treatment. - Para ser utilizado en combinación con rifampicina para el tratamiento de segunda línea de la lepra. 5 For use in patient with HIV receiving protease inhibitors. - Para el uso en pacientes con VIH que reciben inhibidores de proteasa. 6 For treatment of latent tuberculosis infection only Para el tratamiento de la tuberculosis latente unicamente. 7 Procurement of this medicine through the Strategic Fund should be limited for use according to WHO recommended M/XDR-TB regimen in patients for whom there are few or no treatments available. Patients receiving this medicine should be monitored for potential adverse events or related toxicities through national pharmacovigilance programs and data from the WHO Programme for International Drug Monitoring (UPPSALA). - La adquisición de este medicamento a través del Fondo Estratégico debe ser limitada para el uso en pacientes con tuberculosis multi y extensivamente resistente (M-XDR TB) en que hay pocos o ningún tratamiento disponibles y usado según el regimen recomendado por la OMS para M-XDR-TB. Los pacientes que reciben este medicamento deben ser controlados para posibles eventos Page 2 of 12

3 Capreomycin 0.5g; 1g (sulfate) in vial Clofazimine 50mg; 100mg Capsule Cycloserine 250mg Capsule Cycloserine 250mg Delamanid 50mg Ethionamide 125mg ; 250mg Kanamycin 1g (sulfate) in vial Multidrug-resistant tuberculosis Levofloxacin 250mg ; 500mg; 750mg (MDR/TB) Linezolid 600mg 7 Linezolid 100mg/5ml Oral Solution Moxifloxacin 400mg Protionamide 250mg 8 P-aminosalicylic acid 4g in sachet Granule P-aminosalicylate sodium (PAS sodium) 100g (60% w/w) Granules Streptomycin 1g ( sulfate) in vial Terizidone 250mg Capsule 9 Antifungal Amphotericin B 50mg ( sodium deoxycholate or liposomal complex) in vial Antivirals Antiretrovirals Abacavir 60mg (dispersible, scored) Abacavir 300mg Abacavir + Lamivudine 60mg + 30mg; 120mg + 60mg (dispersible, scored) Antifungal; Anti-Lesihmaniasis Abacavir + Lamivudine 600mg + 300mg Atazanavir 100mg Capsule HIV/AIDS Atazanavir 300mg Capsule Atazanavir + Ritonavir 300mg + 100mg Darunavir 75mg; 150mg; 400mg; 600mg; 800mg 10 Dolutegravir 50mg Dolutegravir + Lamivudine + Tenofovir 50mg + 300mg + 300mg Efavirenz 200mg (scored) Efavirenz 600mg Emtricitabine 200mg Capsule 7 adversos o efectos tóxicos relacionados al medicamento a través de programas nacionales de farmacovigilancia y datos del Programa de la OMS para la Vigilancia Farmacéutica Internacional (UPPSALA). 8 Protionamide may be an alternative to ethionamide. La protionamida puede ser utilizada como alternativa a la etionamida. 9 Terizidone may be an alternative to cycloserine. La terizidona puede ser utilizada como alternativa a la cicloserina. 10 Age restriction > 3 years old. Restricción de edad > 3 años de edad. Page 3 of 12

4 Etravirine 100mg; 200mg 11 Lamivudine 150mg Lamivudine 10mg/ml Oral Solution Lamivudine + Zidovudine 30mg +60mg (dispersible, scored) Lamivudine + Zidovudine 150mg+300mg Lopinavir + Ritonavir 100mg + 25mg; (heat 200mg + 50mg stable) Lopinavir + Ritonavir 40mg + 10mg Oral pellets (heat stable) Lopinavir + Ritonavir 80mg+20mg/ml Oral Solution Nevirapine 200mg Nevirapine 50mg (dispersible, scored) Nevirapine 50mg/5ml (100ml) Oral Solution Ritonavir 25mg (heat stable) Ritonavir 100mg (heat HIV/AIDS stable) Ritonavir 400mg/ 5mL (240ml) Oral solution Raltegravir 25mg; 100mg (chewable) 11 Raltegravir 400mg 11 Tenofovir 300mg Tenofovir 200mg Tenofovir + Emtricitabine 300mg + 200mg Tenofovir + Emtricitabine + Efavirenz 300mg + 200mg + 600mg Tenofovir + Lamivudine 300mg + 300mg Capsule Tenofovir + Lamivudine + Efavirenz 300mg + 300mg + 400mg; 300mg + 300mg + 600mg Zidovudine 300mg Zidovudine 60mg (dispersible, scored) Zidovudine 50mg/5ml (100ml) Oral Solution Zidovudine 10mg/ml in 20ml vial Solution for IV Infusion Zidovudine + Lamivudine + Nevirapine 60mg + 30mg + 50mg (dispersible, scored) Zidovudine + Lamivudine + Nevirapine 300mg + 150mg + 200mg Other Antivirals Acyclovir 250mg ( sodium salt) in vial Herpes Virus 11 Procurement of this medicine through the Strategic Fund should be limited for use as third-line therapy in treatment-experienced HIV adults who failed second-line antiretroviral therapy. It is recommended patients receiving HIV/AIDS regimens including this medicine be monitored for potential adverse events or related toxicities through national pharmacovigilance programs and data from the WHO Programme for International Drug Monitoring (UPPSALA). - La adquisición de este medicamento a través del Fondo Estratégico debe ser limitada para su uso como tratamiento de tercera línea en adultos con VIH tratados previamente que reprobaron la terapia antirretroviral de segunda línea. Se recomienda que los pacientes que reciben regímenes de VIH / SIDA que incluyen este medicamento ser monitorizados para detectar posibles eventos adversos o efectos tóxicos relacionados al medicamento a través de los programas nacionales de farmacovigilancia y los datos del Programa de la OMS para la Vigilancia Farmacéutica Internacional (UPPSALA). Page 4 of 12

5 Acyclovir 200mg Oseltamivir 75mg (phosphate) Capsule Oseltamivir 12mg/ml Oral Solution Anti hepatitis medicines Medicines for Hepatitis B Entecavir 0.05mg/ml Oral Solution Entecavir 0.5mg; 1mg Tenofovir disoproxil fumarate 300mg Medicines for Hepatitis C 13 Daclastavir 30mg; 60mg Dasabuvir 250mg Ledipasvir + Sofosbuvir 90mg + 400mg Ombitasvir + Paritaprevir + Ritonavir 12.5mg + 75mg + 50mg Simeprevir 150mg Capsule Sofosbuvir 400mg Sofosbuvir + Velpatasvir 400mg + 100mg Antiprotozoal medicines Antileishmaniasis medicines Meglumine antimoniate 1.5g/ 5 ml (81 mg/ml) in 5ml ampoule Amphotericin B 50mg (sodium deoxycholate or liposomal complex) in vial Miltefosine 10mg; 50 mg Paromomycin Pentamidine Anti-malarial Amodiaquine 750mg of paromomycin base (sulfate) 300mg (isethionate) 153 mg; 200 mg Solution for Intramuscular Influenza Virus (in compliance with WHO treatement guidelines) Chronic Hepatitis B Chronic Hepatitis C Leishmanaiasis Leishmanaiasis Leishmaniasis 14 Malaria treatment to be used in combination with artesunate for P. falciparum. Artemether 80 mg/ml 1 ml ampoule Oily Severe malaria Artemether + Lumefantrine 20 mg mg Malaria treatment Artesunate 60 mg (anhydrous artesunic acid) Severe malaria 15 Artesunate 50 mg; 200mg Rectal Dosage Form Severe malaria According to the 20th World Health Organization Model List of Essential Medicines published in March 2017, Oseltamivir is indicated for severe illness fue to confirmed or suspected influenza virus infection in critically ill hospitalized patients. - De acuerdo con la vigésima Lista Modelo de Medicamentos Esenciales de la Organización Mundial de la Salud publicada en marzo de 2017 Oseltamivir, el uso del oseltamivir es indicado solo en casos confirmados o sospechados de influenza viral en pacientes hospitalizados y en situación de enfermedad critica. (WHO 20th EML 2017) 13 According to the 20th World Health Organization Model List of Essential Medicines published in March 2017 and based on current evidences, medicines of this class act as direct antiviral medicines and are included as essential medicines for treatment of hepatitis C virus infection. WHO guidelines recommend specific combinations therapies utilizing medicines from different classes. - De acuerdo con la vigésima Lista Modelo de Medicamentos Esenciales de la Organización Mundial de la Salud publicada en marzo de 2017 y basándose en la evidencia actual, los medicamentos en esta categoría funcionan como antivirales de acción directa y se incluyen como medicamentos esenciales para el tratamiento de la infección por el virus de la hepatitis C. Las guías de la OMS recomiendan combinaciones terapéuticas específicas con medicamentos de diferentes clases. (WHO 20th EML 2017) 14 This medicine should be used in accordance to the recommendations outlined in the Leishmaniasis in the Americas: Recommendations for the treatment (2013) guide. - Este medicamento debe utilizarse en acuerdo con las recomendaciones formuladas en la guía Leishmaniasis en las Américas: Recomendaciones para el tratamiento (2013). 15 Product may be co-packaged with 1 ampoule of 5% sodium bicarbonate solution and 1 ampoule of sodium chloride solution. - Producto puede ser presentado en conjunto con 1 ampolla de solución de bicarbonato sódico y 1 ampolla de solución de cloruro de sodio. Page 5 of 12

6 Artesunate + Mefloquine 100 mg + 220mg Malaria treatment Artesunate + Amodiaquine 25 mg mg ; 50 mg mg ; 100 mg mg Malaria treatment Atovaquone + Proguanil mg (adult) Atovaquone + Proguanil mg (pediatric) Malaria prophylaxis and treatment Chloroquine 50 mg (phosphate or sulfate)/5 ml Oral Solution Chloroquine 100 mg; 150 mg (phosphate or sulfate) Malaria prophylaxis and treatment Mefloquine 250 mg Malaria prophylaxis; Malaria treatment to be used in combination with artesunate for P. falciparum Dihydroartemisinina + Piperaquina 40 mg mg Malaria treatment As complement to malaria Primaquine 5mg; 7.5 mg ; 15 mg treatment (for radical cure of (diphosphate) P.vivax and P.ovale and as gametocytocide for P. falciparum) Quinine 300 mg quinine hydrochloride/ml in 2ml Severe malaria ampoule Quinine 300 mg (quinine sulfate or bisulfate) Malaria treatment Sulfadoxine + Pyrimethamine 500 mg + 25 mg Malaria treatment to be used in combination with artesunate for P. falciparum Antipneumocystosis and antitoxoplasmosis medicines Pyrimethamine 25mg Sulfamethoxazole + Trimethoprim 80mg + 16mg/ml in 5ml or Pneumocystis; 10ml ampoule Toxoplasmosis Pentamidine 200mg; 300mg Antitrypanosomal medicines 12.5 mg Benznidazole 50 mg (scored) American Trypanosomiasis 100mg Nifurtimox 120mg African Trypanosomiasis (2nd stage); American Trypanosomiasis Anthelminthics Intestinal anthelminthics Albendazole 400mg (chewable) Intestinal Anthelminthic; Anti- Filarial Ivermectin 3mg (scored) Strongyloidiasis Mebendazole 500mg (chewable) Intestinal anthelminthic Niclosamide 500mg Intestinal anthelminthic (for use when praziquantel fails) (chewable) Anticestodes Page 6 of 12

7 Praziquantel 150mg; 600mg Intestinal anthelminthic; Praziquantel 600mg Antischistosomals and Antitrematode Medicines Triclabendazole 250mg Antifilarials Dietylcarbamazine 50mg; 100mg (dihydrogen citrate) ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MED. USED IN PALLIATIVE CARE Immunosuppressive Agents Azathioprine 100mg (sodium salt) in vial Antischistosomal; Antitrematode; Anticestode Antitischistosomal; Antitrematode Filariasis Immunosuppressive Azathioprine 50mg DMARD Cyclosporine 25mg Capsule Cyclosporine 50mg/ml in 1ml ampoule Mycophenolate Mofetil Tacrolimus Cytotoxic medicines Asparaginase Bleomycin 250 mg Capsules 500 mg s Capsules 0.5, 1, 5 mg (immediate release) 10,000 IU in vial 15mg (sulfate) in vial Immunosuppressive Prophylaxis of organ rejection in adult patients receiving allogeneic renal transplants Prophylaxis of organ rejection in adult patients receiving allogeneic renal or hepatic transplants Cytotoxic Agent Calcium folinate 3mg/ml in 10ml ampoule Calcium folinate 15mg Adjuvant Medicine Carboplatin 150mg; 450mg Cytotoxic and Adjuvant Medicine Chlorambucil 2mg Cytotoxic Agent Cisplatin 10mg; 50mg Cytotoxic and Adjuvant Medicine Cyclophosphamide 500mg in vial Cytotoxic Agent Cyclophosphamide 25mg Cytarabine 100mg in vial Dacarbazine 100mg in vial Dactinomycin 500µg in vial Cytotoxic Agent Daunorubicin 50mg in vial Docetaxel 20mg/ml Cytotoxic and Adjuvant Medicine 10mg; 50mg Doxorubicin in vial Cytotoxic Agent Etoposide 100mg Capsule Etoposide 20mg/ml in 5ml ampoule Fluorouracil 50mg/ml in ampoule Cytotoxic and Adjuvant Medicine Page 7 of 12

8 Ifosfamide 1g vial Cytotoxic and Adjuvant Medicine Mercaptopurine 50mg Cytotoxic Agent Mesna (2-mercaptoethane sulfonate 100mg/ml in 4ml and 10ml sodium) ampoules Adjuvant Medicine Methotrexate 50mg (sodium salt) in vial Cytotoxic Agent Methotrexate 2.5mg (sodium salt) Cytotoxic Agent; DMARD Paclitaxel 6mg/ml Cytotoxic and Adjuvant Medicine Procarbazine 50mg Capsule Cytotoxic Agent Tamoxifen 10mg; 20mg (citrate) Hormone/Anti-Hormone Trastuzumab 150 & 440 mg HER2+ early breast cancer Vinblastine 10mg (sulfate) in vial Vincristine 1mg; 5mg (sulfate) in vial Cytotoxic Agent BLOOD PRODUCTS AND PLASMA SUBSTITUTES Plasma fractions for specific use Human normal immunoglobulin 16% protein solution for Intramuscular Administration Human normal immunoglobulin Coagulation factor VIII Coagulation factor IX 5% protein solution; 10% protein solution 500UI/vial 500UI/vial; 1000UI/vial for Intravenous Administration Plasma fractions for specific use Blood coagulation factors IMMUNOBIOLOGICS Sera and immunoglobulins Prevention of newborn hemolytic anti-d immunoglobulin (human) illnesses; 250µg in single-dose vial Rh negative populations (prophylaxis) CARDIOVASCULAR MEDICINES Antihypertensive medicines Amlodipine 5mg (maleate, mesylate or besylate) Antihypertensive Bisoprolol 1.25mg; 5mg Antihypertensive; Antianginal; Carvedilol 3.125mg; 6.25mg; 12.5mg; Antiarrhythmic; Medicines used in 25mg; 50mg heart failure Chlorthalidone 12.5mh; 25mg Hypertension in adults Enalapril 2.5mg; 5mg (hydrogen Antihypertensive; Medicines used maleate) in heart failure Hydralazine 20mg in ampoule Hypertension Indicated for primary immune deficiency. - Indicado para deficiencia inmune primaria. 17 Indicated for primary immune deficiency and Kawasaki disease. - Indicado para deficiencia inmune primaria y enfermedad de Kawasaki. 18 Metoprolol and carvedilol as alternatives. - Alternativos: metoprolol y carvedilol. Page 8 of 12

9 Hydralazine 25mg; 50mg Hypertension Hydrochlorothiazide 12.5mg; 25mg Antihypertensive; Medicines used in heart failure; Diuretics Losartan 25mg; 50mg; 100mg s Hypertension in adults 19 Methyldopa 250 mg Antihypertensive 20 Metoprolol 100mg Sodium nitroprusside Surfactant (Surfactante pulmonar exogeno) Antiarrhythmic medicines Amiodarone 50mg in ampoule 25mg/ml; 80mg/ml 100 mg; 200 mg; 400 mg 50 mg / ml in 3 ml ampoule 250 micrograms/ml in 2 ml ampoule Infusion Suspension for Intratracheal Instillation Antihypertensive; Antianginal; Antiarrhythmic; Medicines used in heart failure Hypertension Neonatal care Antiarrythmic Antiarrythmic Medicines used in heart failure Digoxin 62.5 micrograms; 250 micrograms 50 micrograms/ml Oral Solution Lidocaine 20 mg /ml in 5 ml ampoule Antiarrythmic Verapamil 2.5 mg /ml in 2 ml ampoule Antiarrythmic 40 mg; 80 mg Antianginal medicines Diuretics Spironolactone 25mg Diuretic Antianginal medicines Glyceryl trinitrate 500µg (sublingual) Angina Antithrombotic medicines Clopidogrel 75 mg Prevention of atherothrombotic events in adults with non-st segment elevation acute coronary syndrome Streptokinase 1.5million IU in vial Thrombosis Lipid-lowering agents Simvastatin 5mg; 10mg; 20mg; 40mg Lipid-Lowering Agents 19 Losartan can be used as an alternative for treatment of adults with hypertension for those patients in whom ACEi are indicated but not tolerated, specifically due to the presence of adverse events (mainly cough); including the sub-population of hypertensive patients associated with type II diabetes with proteinuria. - Losartan puede ser utilizado como una alternativa para el tratamiento de hipertensión en adultos, para aquellos pacientes en los cuales los IECA están indicados pero no se toleran, específicamente debido a la presencia de eventos adversos (principalmente la tos); incluyendo la sub-población de pacientes hipertensos con asociación de diabetes tipo II con proteinuria. 20 Methyldopa is listed for use only in the management of pregnancy induced hypertension. Its use in the treatment of essential hypertension is not recommended in view of the evidence of greater efficacy and safety of other medicines (WHO 20 th EML). - Metildopa se lista sólo para su uso en el manejo de la hipertensión inducida por el embarazo. Su uso en el tratamiento de la hipertensión esencial no se recomienda basado en la evidencia de una mayor eficacia y seguridad de otros medicamentos (20 a LME OMS). Page 9 of 12

10 DIAGNOSTIC AGENTS Radiocontrast media Amidotrizoate 140mg to 420mg iodine (sodium or Meglumine Radiocontrast Media salt)/ml in 20ml ampoule HORMONES, ENDOCRINE MED. Contraceptives Oral hormonal contraceptives Ethinylestradiol + levonorgestrel 30µg + 150µg Ethinylestradiol + norethisterone 35µg + 1.0mg Contraception Levonorgestrel 30µg; 750µg (pack of two); 1.5mg Contraception Injectable hormonal contraceptives Medroxyprogesterone acetate 150mg/ml in 1ml vial. Depot Medroxyprogesterone acetate + Contraception 25mg + 5mg estradiol cypionate Norethisterone enantate 200mg/ml in 1ml ampoule Oily Contraception Insulins and other antidiabetic agents Insulin soluble 40 IU/ml; 100 IU/ml in 10ml vial Intermediate-acting insulin 40 IU/ml; 100 IU/ml in 10ml vial (coumpound insulin zinc suspension or isophane Diabetes insulin) Glibenclamide 2.5mg; 5mg Metformin 500mg MEDICINES AFFECTING THE BLOOD Antianaemia medicines Recombinant Human Erythropoietin 2,000-5,000 UI/ml Recombinant Human Erythropoietin 20,000-50,000 UI/ml Anemia Medicines affecting coagulation Warfarin 0.5mg; 1mg; 2mg; 5mg (sodium salt) Anticoagulant ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS Dexamethasone 4mg/ml in 1ml ampoule (disodium phosphate salt) Antiemetic; Anti-allergic /Anaphylaxis; Cytotoxic; Palliative care Dexamethasone 2 mg Palliative care 100mg (sodium succinate) in Anaphylaxis; Hydrocortisone vial Cytotoxic MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS Vecuronium 10mg (bromide) in vial OXYTOCICS AND ANTIOXYTOCICS Oxytocics Oxytocin 10 UI in 1 ml ampoule Ergometrine 200µg (hydrogen maleate) in 1ml ampoule Mifepristone Misoprostol 200mg - 200µg s Misoprostol 200µg ANTICONVULSANT AND ANTIEPILEPTIC Phenytoin 25mg; 50mg; 100mg (sodium salt) Capsule Muscle Relaxant Oxytocic Oxytocic Anticonvulsant; Page 10 of 12

11 Phenytoin 50mg/ml (sodium salt) in 5ml vial Phenytoin 25mg/5 ml; 30mg/5 ml Oral Solution Phenobarbital 50mg/ml in 5ml vial (sodium salt) Phenobarbital 15mg/5 ml Oral Solution Phenobarbital 15mg; 100mg Carbamazepine 100mg/5 ml Oral Solution Carbamazepine 100mg; 200mg (chewable) Carbamazepine 100mg; 200mg (scored) Diazepam Magnesium sulfate 5mg/ml in 0.5ml; 2ml; 4ml tubes 500mg/ml in 2ml or 10ml ampoule 200mg; 500mg (sodium valproate) Gel or; Rectal solution (entericcoated) Valproic acid 100mg (crushable) 200mg/5ml Oral solution 100mg/ml in 4ml ampoule; 100mg/ ml in 10ml ampoule PSYCHOTHERAPEUTIC MEDICINES Chlorpromazine 25mg /ml in 2ml ampoule. Chlorpromazine 25mg /5 ml Oral Solution Chlorpromazine 100mg Fluphenazine 25mg (decanoate or enantate) in 1ml ampoule Haloperidol 5mg in 1ml ampoule Haloperidol 2mg; 5mg Antiepileptic Anticonvulsant; Antiepileptic Anticonvulsant; Antiepileptic Medicine used in bipolar disorders Anticonvulsant; Antiepileptic Psychotic Disorders Medicines used in mood disorders Amitriptyline 10mg; 25mg Palliative Care; Depressive Disorders Fluoxetine 20mg Capsule Palliative Care; Fluoxetine 20mg Depressive Disorders Medicines used in bipolar disorders Lithium carbonate 300mg Capsule Lithium carbonate 300mg Bipolar Disorder Medicines used for disorders due to psychoactive substance use Nicotine replacement therapy (gums) 2mg; 4mg (as polacrilex) Gums Nicotine replacement therapy (patch) 5mg to 30mg/16 h; Transdermal Tobacco cessation 7mg to 21mg/24h patch Treatment with 10mg should be utilized only in palliative care. - Tratamiento con 10mg solo debería ser utilizado en cuidados paliativos. Page 11 of 12

12 ANTIPARKINSONISM MEDICINES Biperiden 5mg (lactate) in 1ml ampoule Biperiden 2mg GASTROINTESTINAL MEDICINES Antiulcer Medicines Omeprazole oral 20 mg; 40 mg liquid in Sachets 10 mg; 20 mg; 40 mg Solid oral dosage form 25 mg/ml (as hydrochloride) in 2-ml ampoule Ranitidine 150 mg (as hydrochloride) 75 mg/5 ml (as hydrochloride) Oral Solution MEDICINES ACTING ON THE RESPIRATORY TRACT Antiasthmatic and medicines for chronic obstructive pulmonary disease Beclometasone Ipratropium bromide Salbutamol OTHERS 50 micrograms (dipropionate) per dose; 100 micrograms (dipropionate) per dose (as CFC free forms) 20 micrograms/metered dose 100 micrograms (as sulfate) per dose 50 micrograms (as sulfate)/ml 100 micrograms (as sulfate) per dose 5 mg (as sulfate)/ml Inhalation (aerosol) Inhalation (aerosol) Inhalation (aerosol) in 5 ml ampoule Metered dose inhaler (aerosol) Respirator solution for use in nebulizers Calcium gluconate 100mg/ml in 10ml ampoule Parkinson s Disease Antiulcer medicines Antiasthmatic Medicines used for chronic obstructive pulmonary disease (COPD) Specific Use Antidotes and Others Substances Used in Poisoning; Vitamins and Minerals Page 12 of 12

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs page 1 CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs 2011 The following categories are included in this work programme: 1. Medicines

More information

1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017

1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017 To support national and global efforts to increase access to and the affordability of care and treatment of HIV/AIDS, hepatitis B and C, tuberculosis, malaria, neglected tropical diseases, influenza, diarrhoea

More information

WHO Model List (revised April 2002)

WHO Model List (revised April 2002) Essential Medicines Explanatory Notes The complementary list presents essential medicines for priority diseases which are efficacious, safe and cost-effective but not necessarily affordable, or for which

More information

poor solubility and poor permeability unknown whether poor BA is due to poor solubility or antiglaucoma medicine for biowaiver Not eligible

poor solubility and poor permeability unknown whether poor BA is due to poor solubility or antiglaucoma medicine for biowaiver Not eligible Table 1 Substances on the WHO Model List of Essential Medicines (EML) Medicine a abacavir 200 mg high low 3 9.2.1.2 antiretroviral acetazolamide 250 mg low low (?) 4/2 antiglaucoma acetylsalicylic acid

More information

EML 14 COMPLEMENTARY LIST

EML 14 COMPLEMENTARY LIST 1. ANAESTHETICS 1.1 General anaesthetics and oxygen 1.2 Local anaesthetics ephedrine injection, 30mg (hydrochloride)/ml in 1-ml (see comment) 3mg/ml in 1mL, 10mL For reversal of hypotension from epidural

More information

Appendix 5: Hepatic impairment

Appendix 5: Hepatic impairment Appendix 5: Hepatic impairment Liver disease may alter the response to drugs. However, the hepatic reserve appears to be large and liver disease has to be severe before important changes in drug metabolism

More information

Appendix 4: Renal impairment

Appendix 4: Renal impairment Appendix 4: Renal impairment Reduced renal function may cause problems with drug therapy for the following reasons: 1. The failure to excrete a drug or its metabolites may produce toxicity. 2. The to some

More information

Appendix 1: Interactions

Appendix 1: Interactions Appendix 1: Interactions Two or more drugs given at the same time may interact with each other. The interaction may be potentiation or antagonism of one drug by another, or occasionally some other. Drug

More information

WHO Model List of Essential Medicines

WHO Model List of Essential Medicines of Essential Medicines 17th list (March 2011) Status of this document This is a reprint of the text on the WHO Medicines web site http://www.who.int/medicines/publications/essentialmedicines/en/index.html

More information

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016 To support national and global efforts to increase access to and the affordability of HIV/AIDS-related care and treatment together with UNICEF, UNAIDS and UNITAID, invite applicants for selected pharmaceutical

More information

Invitation to Manufacturers 16 August 2017

Invitation to Manufacturers 16 August 2017 Invitation to Manufacturers 16 August 2017 Manufacturers of Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial medicines Are Invited to Submit An Expression of Interest

More information

WHO Model List of Essential Medicines

WHO Model List of Essential Medicines of Essential Medicines 15 th list, March 2007 Status of this document This is a reprint of the text on the WHO Medicines web site http://www.who.int/medicines/publications/essentialmedicines/en/index.html

More information

Essential Medicines 15th edition (March 2007) WHO Model List (revised March 2007)

Essential Medicines 15th edition (March 2007) WHO Model List (revised March 2007) Explanatory Notes The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost effective medicines for priority conditions. Priority

More information

Syria Essential Drugs List (EDL) Priority 2014

Syria Essential Drugs List (EDL) Priority 2014 Syria Essential Drugs List (EDL) Priority 2014 1. ANAESTHETICS Quantities halothane Inhalation. 10.000 isoflurane Inhalation. 30.000 sevoflurane bottle (quick fill bottle adapter ) Inhalation. 10.000 nitrous

More information

Compendium of Notified Ceiling Prices NLEM 2015

Compendium of Notified Ceiling Prices NLEM 2015 Compendium of Notified Ceiling Prices NLEM 2015 The Compendium of Notified Ceiling Prices of Scheduled Drugs as per NLEM 2015 has been brought out with the objective of disseminating information related

More information

Il programma dei farmaci essenziali dell OMS, la nuova lista marzo Suzanne Hill Department of Medicines Policy and Standards WHO

Il programma dei farmaci essenziali dell OMS, la nuova lista marzo Suzanne Hill Department of Medicines Policy and Standards WHO Il programma dei farmaci essenziali dell OMS, la nuova lista marzo 2007 Suzanne Hill Department of Medicines Policy and Standards WHO Essential medicines 30 years on Outline A review of 30 years of essential

More information

WHO Model List of Essential Medicines

WHO Model List of Essential Medicines of Essential Medicines 19th List (April 2015) (Amended June 2015) Status of this document This is a reprint of the text on the WHO Medicines website http://www.who.int/medicines/publications/essentialmedicines/en/

More information

First DRAFT: WHO Model List of Essential Medicines for Children Explanatory notes

First DRAFT: WHO Model List of Essential Medicines for Children Explanatory notes First DRAFT: WHO Model List of Essential Medicines for Children Explanatory notes 1. The aim of the list is to identify medicines, dosage forms and strengths that are essential for children aged 12 years

More information

WHO Model List of Essential Medicines for Children Explanatory Notes

WHO Model List of Essential Medicines for Children Explanatory Notes WHO Model List of Essential Medicines for Children Explanatory Notes This Model List is intended for use for children up to 12 years of age. 16 August 2007 The core list presents a list of minimum medicine

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No. LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml

More information

WHO Model List (revised April 2002)

WHO Model List (revised April 2002) Essential Medicines Explanatory Notes The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost-effective medicines for priority

More information

LIST OF ESSENTIAL MEDICINES OF RA

LIST OF ESSENTIAL MEDICINES OF RA 1. ANAESTHETICS 1) General anaesthetics and oxygen Inhalational medicines Nitrous Oxide Oxygen Halothane Isoflurane Injectable medicines Ketamine Propofol Thiopental Fentanyl 2) Local anaesthetics Bupivacaine

More information

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH 1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

LIST OF ESSENTIAL MEDICINES OF RA

LIST OF ESSENTIAL MEDICINES OF RA a/ Core List LIST OF ESSENTIAL MEDICINES OF RA 1. Anaesthetics 1.1. General anaesthetics and oxygen Nitrous oxide Inhalation Thiopental Powder for injection: 0.5 g, 1.0 g, (sodium salt) Oxygen Inhalation

More information

WHO Model List (revised March 2005) Explanatory Notes

WHO Model List (revised March 2005) Explanatory Notes 14 th edition (March 2005) Essential Medicines Explanatory Notes The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost-effective

More information

WHO Model List of Essential Medicines for Children

WHO Model List of Essential Medicines for Children WHO Model List of Essential Medicines for Children 2nd List, March 2009 Status of this document This is a reprint of the text on the WHO Medicines web site http://www.who.int/medicines/publications/essentialmedicines/en/index.html

More information

Chapter 5 ~ Infections

Chapter 5 ~ Infections Chapter 5 ~ Infections: Special Section 1 of 6 Chapter 5 ~ Infections Please refer to The Hillingdon Hospitals NHS Trust Antibiotic Guidelines, Policy number 233, and Surgical Prophylaxis Policy, Policy

More information

Inventory of paediatric therapeutic needs

Inventory of paediatric therapeutic needs 12 December 2012 EMA/PDCO/287222/2012 Human Medicines Development and Evaluation Infectious diseases Agreed by PDCO November 2012 Adopted by PDCO for release for consultation 7 December 2012 Start of public

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

(To be Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary)

(To be Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) (To be Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

WHO Model List of Essential Medicines for Children

WHO Model List of Essential Medicines for Children Essential Medicines for Children 5th List (April 2015) (Last amended June 2015) Status of this document This is a reprint of the text on the WHO Medicines website http://www.who.int/medicines/publications/essentialmedicines/en/

More information

قائمة األدوية األساسية للمملكة العربية السعودية

قائمة األدوية األساسية للمملكة العربية السعودية قائمة األدوية األساسية للمملكة العربية السعودية النسخة الثانية 2018 Essential Medicines of Saudi Arabia 2 nd List -2018 Class Generic Name Dosage Form Strength (Volume) 1 Anesthetics, Preoperative Medicines.

More information

WHO Model List of Essential Medicines

WHO Model List of Essential Medicines WHO Model List of Essential Medicines 20th List (March 2017) (Amended August 2017) Status of this document This is a reprint of the text on the WHO Medicines website http://www.who.int/medicines/publications/essentialmedicines/en/

More information

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500

More information

The Global Health Impact Index

The Global Health Impact Index The Global Health Impact Index Ranking Explanation Reference Table Drug Abbreviation Drug Name 1. AL 1. Artemether-Lumefantrine 2. AS+AQ 2. Artesunate + Amodiaquine 3. AS+MQ 3. Artesunate + Mefloquine

More information

WHO Model List of Essential Medicines for Children

WHO Model List of Essential Medicines for Children WHO Model List of Essential Medicines for Children 6th List (March 2017) (Amended August 2017) Status of this document This is a reprint of the text on the WHO Medicines website http://www.who.int/medicines/publications/essentialmedicines/en/

More information

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364 G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288

More information

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Monographs on ARV and hepatitis medicines in The International Pharmacopoeia

Monographs on ARV and hepatitis medicines in The International Pharmacopoeia Monographs on ARV and hepatitis medicines in The International Pharmacopoeia Technologies, Standards and Norms 1 The International Pharmacopoeia contains analytical methods and specifications for active

More information

An introduction to the Essential Medicines concept: balancing innovation with public health priorities

An introduction to the Essential Medicines concept: balancing innovation with public health priorities An introduction to the Essential Medicines concept: balancing innovation with public health priorities WHO HQ, Geneva 11 October 2017 Nicola Magrini Secretary, WHO Expert Committee on the Selection and

More information

Professionalism & Service with Great Prices

Professionalism & Service with Great Prices Acyclovir Capsules 200mg Viruses 30 90 Albuterol Syrup 2mg/5ml Asthma 120 360 Albuterol Sulfate Solution 0.05% * Asthma ----- ----- 20 60 Albuterol Sulfate Solution 0.083% Asthma ----- ----- 75 225 Alendronate

More information

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5

More information

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017 Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Cash Wise Pharmacy $4 GENERIC MEDICATION FORMULARY. Cash Wise Pharmacy s $4 generic medication formulary is sorted by medical condition.

Cash Wise Pharmacy $4 GENERIC MEDICATION FORMULARY. Cash Wise Pharmacy s $4 generic medication formulary is sorted by medical condition. Cash Wise Pharmacy $4 GENERIC MEDICATION FORMULARY Cash Wise Pharmacy s $4 generic medication formulary is sorted by medical condition. 30- day 90- day 30- day 90- day quantity quantity quantity quantity

More information

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,

More information

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,

More information

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017 Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine

More information

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010 Priority essential medicines: identifying products Dr Suzanne Hill September 2010 The problem looks like this Robertson, Forte, Trapsida & Hill. Bull WHO 2009 Robertson, Forte, Trapsida & Hill. Bull WHO

More information

Ketamine-ADDED. Nitrous Oxide Oxygen Thiopental. 1.2 Local anaesthetics Bupivacaine

Ketamine-ADDED. Nitrous Oxide Oxygen Thiopental. 1.2 Local anaesthetics Bupivacaine 1. ANAESTHETICS 1.1 General anaesthetics and oxygen Sevoflurane-ADDED Ketamine-ADDED Nitrous Oxide Oxygen Thiopental 1.2 Local anaesthetics Bupivacaine Inhalation: Newer agent replacing halothane Lower

More information

(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary)

(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

List of changes in Out-Patients Formulary

List of changes in Out-Patients Formulary List of changes in Out-Patients Formulary Change in prescriber criteria Alpha Tocopheryl (Vitamin E) suspension 100mg/mL, tablets 50-150mg, tablets 670mg Atorvastatin tablets Bezafibrate tablets 400mg

More information

Supplementary Data. Supplementary Table S2. Antiretroviral Therapies Taken with Ledipasvir/Sofosbuvir

Supplementary Data. Supplementary Table S2. Antiretroviral Therapies Taken with Ledipasvir/Sofosbuvir Supplementary Data Statistical Analysis Due to the limited number of patients with acute kidney injury and concern for model overfitting, covariates included in multivariable logistic regression analyses

More information

Drug Name. Code Artesunate Injection 60 mg/ml Chloroquine Phosphate Injection 40 mg/ml

Drug Name. Code Artesunate Injection 60 mg/ml Chloroquine Phosphate Injection 40 mg/ml Sr.No New Drug Code Drug Name 1 26.1.275.2 Artesunate Injection 60 mg/ml 2 26.1.277.2 Chloroquine Phosphate Injection 40 mg/ml 3 26.1.277.4 Chloroquine Phosphate Tablet 250 mg, equivalent to 155 mg chloroquine

More information

Alaska Medicaid 90 Day** Generic Prescription Medication List

Alaska Medicaid 90 Day** Generic Prescription Medication List 1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL

More information

MEDICINES CATALOG NOVEMBER 2018 GLOBAL DRUG FACILITY (GDF)

MEDICINES CATALOG NOVEMBER 2018 GLOBAL DRUG FACILITY (GDF) NOVEMBER 2018 MEDICINES CATALOG GLOBAL DRUG FACILITY (GDF) Ensuring an uninterrupted supply of quality-assured, affordable tuberculosis (TB) medicines and diagnostics to the world. stoptb.org/gdf Stop

More information

Annex 8 Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms

Annex 8 Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 8 Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral

More information

WEB ANNEX J. TABLE OF DRUG INTERACTIONS WITH ANTIRETROVIRAL DRUGS

WEB ANNEX J. TABLE OF DRUG INTERACTIONS WITH ANTIRETROVIRAL DRUGS WEB ANNEX J. TABLE OF DRUG INTERACTIONS WITH ANTIRETROVIRAL DRUGS In: Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on

More information

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.

90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15. 90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.00 Allergy/Cold&Flu C-Phen Drops n/a Drops 90 $15.00 Allergy/Cold&Flu

More information

CEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins

CEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Report generated from BNF - Local Information provided by FormularyComplete (www.pharmpress.com). Accessed 31 07 2017 Title Formulary Status Section Amikacin Non Formulary 5.1 Antibacterial drugs->5.1.4

More information

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6 Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;

More information

injection:50 mg (as hydrochloride)/ml in 10-ml vial nitrous oxide powder for injection:0.5 g; 1.0 g (sodium salt) in ampoule

injection:50 mg (as hydrochloride)/ml in 10-ml vial nitrous oxide powder for injection:0.5 g; 1.0 g (sodium salt) in ampoule Code Can be used at all levels of health care (health post, health centre, hospital) Should be used by a doctor only Should be used by / under instruction of a specialist Restricted for indication stated

More information

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 The Prescription Savings Club provides its members with significant savings on prescription medications. The

More information

VMG Pharmaceuticals Pvt. Ltd.

VMG Pharmaceuticals Pvt. Ltd. S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets

More information

Biowaiver for Immediate Release Solid Oral Dosage Form: A General Overview

Biowaiver for Immediate Release Solid Oral Dosage Form: A General Overview Human Journals Review Article August 2018 Vol.:13, Issue:1 All rights are reserved by Tekendra Pant et al. Biowaiver for Immediate Release Solid Oral Dosage Form: A General Overview Keywords: Biowaiver,

More information

Rifamycins Drug interactions

Rifamycins Drug interactions Rifamycins Drug interactions Drug Category Drug / Drug Class Antacids Nature of Interaction absorption of rifamycins Recommendations Give 1 hour prior to Antacid use Acid Blocking Agents Proton Pump Inhibitors

More information

Antimycobacterial drugs. Dr.Naza M.Ali lec Dec 2018

Antimycobacterial drugs. Dr.Naza M.Ali lec Dec 2018 Antimycobacterial drugs Dr.Naza M.Ali lec 14-15 6 Dec 2018 About one-third of the world s population is infected with M. tuberculosis With 30 million people having active disease. Worldwide, 9 million

More information

Appropriate Use & Safety Edits

Appropriate Use & Safety Edits Appropriate Use & Safety Edits Envolve Pharmacy Solutions provides a variety of safety edits to promote the use of the right medication, in the right patient, at the right time. These edits are routinely

More information

Medicines recommended to prevent and manage the priority diseases at the community and health facility level

Medicines recommended to prevent and manage the priority diseases at the community and health facility level s recommended to prevent and manage the priority diseases at the community and health facility level Shamim Qazi Department of Child and Adolescent Health and Development Global Causes of Child Deaths

More information

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product

More information

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product

More information

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO Ont. Drug Distr. Ontario Drug Benefit/Trillium: Other Formulary (F/A) Limited Use (Section 16) Antiretrovirals AZT 100 mg capsules NRTIs (single): Abacavir,

More information

Special Generic Drug Pricing Program

Special Generic Drug Pricing Program FREE PICK-UP & DELIVERY Flu-Shots Specialty prescription Compounding Wellness center providing health screenings for hypertension and diabetes $3 Special Generic Prescription Drug Program only offered

More information

The International Pharmacopoeia - Overview

The International Pharmacopoeia - Overview The International Pharmacopoeia - Overview Caroline Mendy - Technical Officer Quality Assurance and Safety: Medicines World Health Organization 1 The International Pharmacopoeia Ph. Int. Scope WHO Consultative

More information

PROGRAM General Information

PROGRAM General Information Association for Quality Assessment in TDM and Clinical Toxicology Section of the Dutch Foundation for Quality Assessment in Medical Laboratories PROGRAM 2016 General Information P.O. Box 43100, 2504 AC

More information

Regional bulletin for the availability of antimalarial medicines: Third Quarter 2015

Regional bulletin for the availability of antimalarial medicines: Third Quarter 2015 Regional bulletin for the availability of antimalarial medicines: Third Quarter 2015 Volume 3 Number 1 2015 www.paho.org/prais This bulletin is developed through a collaborative effort between the National

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

Generic Drug List - Alphabetical

Generic Drug List - Alphabetical Generic Drug List - Alphabetical *** Individual pages can be printed by entering the page number in the Print Range field of the Print menu (Ctrl+P)*** Medication Name Category 30-Day 90-Day ACYCLOVIR

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment

More information

Product List Finished Dosage Forms (FDF) B2B Business

Product List Finished Dosage Forms (FDF) B2B Business Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium

More information

Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1

Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1 Antimalarials in the WHO Essential Drugs List for Children Reviewer No.1 Part I: Evaluation of the current list Proposed grouping from the March 2007 meeting 6.5.3 Antimalarial medicines 6.5.3.1 For curative

More information

CMI Marketplace 2015 (List of Covered Drugs)

CMI Marketplace 2015 (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 fentanyl citrate 200 mcg lozenge hd morphine sulfate 30 mg tablet er oxymorphone hcl 7.5 mg tab er 12h Opioid Analgesics, Short-acting

More information

TennCare Program TN MAC Price Change List As of: 03/30/2017

TennCare Program TN MAC Price Change List As of: 03/30/2017 1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017

More information

$4 Prescription Program May 5, 2008

$4 Prescription Program May 5, 2008 Allergies & Cold and Flu Benzonatate 100mg 14 42 Ceron DM syrup 120ml 360ml Ceron drops* 30ml 90ml Dec-Chlorphen drops* 30ml 90ml Dec-Chlorphen DM syrup* 118ml 354ml Loratadine 10mg 30 90 Promethazine

More information

DISCLAIMER (Updated as on )

DISCLAIMER (Updated as on ) DISCLAIMER The information contained herein is not a substitute to ceiling prices notified in the Gazette of India Extraordinary. For the official version, please refer to the relevant Gazette Notification

More information

Elizabeta Zisovska, Skopje, Republic of Macedonia

Elizabeta Zisovska, Skopje, Republic of Macedonia Elizabeta Zisovska, Skopje, Republic of Macedonia The comments are extracted and supported by the Drug register (for registered drugs in Republic of Macedonia) issued by the ministry of health, Republic

More information

EML- ANTIRETROVIRALS INTERACTIONS TABLE

EML- ANTIRETROVIRALS INTERACTIONS TABLE EML- ANTIRETROVIRALS INTERACTIONS TABLE February 2019 6 th Edition Medicines Information Centre Division of Clinical Pharmacology University of Cape Town Copyright 2019 National HIV & TB HCW Hotline, Medicines

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 37 1. NAME OF THE MEDICINAL PRODUCT Tablets* 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg efavirenz, 200 mg emtricitabine

More information

Chapter 2 ~ Cardiovascular system

Chapter 2 ~ Cardiovascular system Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection

More information

Product Dose Form Strength RH DH HC HP

Product Dose Form Strength RH DH HC HP GUYANA EDL 2009-2010 Product Dose Form Strength RH DH HC HP 1 1.01 1.01.01 1.01.02 1.02 1.03 Anaesthetics General Anaesthetics and oxygen Intravenous Ketamine Injection 50mg/ml Thiopentone Sodium 0.5g

More information

State of Maine Department of Health & Human Services MaineCare/MEDEL Prior Authorization Form HEPATITIS C TREATMENT

State of Maine Department of Health & Human Services MaineCare/MEDEL Prior Authorization Form HEPATITIS C TREATMENT State of Maine Department of Health & Human Services MaineCare/MEDEL Prior Authorization Form HEPATITIS C TREATMENT HCV Phone: 1-888-445-0497 www.mainecarepdl.org Fax: 1-888-879-6938 Member ID #: Patient

More information

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 36 1. NAME OF THE MEDICINAL PRODUCT mg/300 mg Tablets* 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg efavirenz, 200 mg

More information

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications Daclatasvir/Sofosbuvir (Daklinza /Sovaldi TM ) Drug Interactions A Quick Guide for Clinicians April 2017 John J Faragon, PharmD, BCPS, AAHIVP Mechanism of Action and Route of Metabolism for Daclatasvir

More information

RETAIL PRESCRIPTION PROGRAM DRUG LIST -- WALMART Revised 8/24/11

RETAIL PRESCRIPTION PROGRAM DRUG LIST -- WALMART Revised 8/24/11 Allergies & Cold and Flu $4, 30-day $10, 90-day Benzonatate 100mg cap 14 42 Loratadine 10mg tab 30 90 Promethazine DM syrup 120ml 360ml Antibiotic Treatments Amoxicillin 125mg/5ml susp (80ml bottle) 1

More information

Approved USP Compounded Monographs

Approved USP Compounded Monographs APPROVED USP COMPOUNDED MONOGRAPHS Acacia Syrup Acetazolamide Oral Suspension Acetylcysteine Compounded Solution Diluted Acetic Acid Diluted Alcohol Allopurinol Oral Suspension Alprazolam Oral Suspension

More information

IMPLEMENTATION OF THE REVISED GENERAL

IMPLEMENTATION OF THE REVISED GENERAL July 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 IMPLEMENTATION OF THE REVISED GENERAL MONOGRAPH ON PARENTERAL

More information